These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6684724)

  • 1. Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria.
    Wilcken DE; Reddy SG; Gupta VJ
    Metabolism; 1983 Apr; 32(4):363-70. PubMed ID: 6684724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts.
    Boers GH; Fowler B; Smals AG; Trijbels FJ; Leermakers AI; Kleijer WJ; Kloppenborg PW
    Hum Genet; 1985; 69(2):164-9. PubMed ID: 3972418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency.
    Dudman NP; Wilcken DE
    Clin Chim Acta; 1983 Jan; 127(1):105-13. PubMed ID: 6825304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.
    Lu YH; Cheng LM; Huang YH; Lo MY; Wu TJ; Lin HY; Hsu TR; Niu DM
    Clin Nutr; 2015 Dec; 34(6):1155-8. PubMed ID: 25516282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental homocysteinemia in pigs: comparison with studies in sixteen homocystinuric patients.
    Reddy GS; Wilcken DE
    Metabolism; 1982 Aug; 31(8):778-83. PubMed ID: 7098848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homocysteine response to methionine challenge in four obligate heterozygotes for homocystinuria and relationship with cystathionine beta-synthase mutations.
    Sperandeo MP; Candito M; Sebastio G; Rolland MO; Turc-Carel C; Giudicelli H; Dellamonica P; Andria G
    J Inherit Metab Dis; 1996; 19(3):351-6. PubMed ID: 8803779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease.
    Boers GH; Smals AG; Trijbels FJ; Fowler B; Bakkeren JA; Schoonderwaldt HC; Kleijer WJ; Kloppenborg PW
    N Engl J Med; 1985 Sep; 313(12):709-15. PubMed ID: 4033695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocystinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients.
    Wilcken DE; Dudman NP; Tyrrell PA
    Metabolism; 1985 Dec; 34(12):1115-21. PubMed ID: 3934499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype.
    Guttormsen AB; Ueland PM; Kruger WD; Kim CE; Ose L; Følling I; Refsum H
    Am J Med Genet; 2001 May; 100(3):204-13. PubMed ID: 11343305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of heterozygotes for homocystinuria. Study of sulphur-containing amino acids in plasma and urine after L-methionine loading.
    Sardharwalla IB; Fowler B; Robins AJ; Komrower GM
    Arch Dis Child; 1974 Jul; 49(7):553-9. PubMed ID: 4851308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocysteine and coronary heart disease. Is slight or moderate homocysteinemia related to increased risk of coronary heart disease?].
    Donner MG; Schwandt P; Richter WO
    Fortschr Med; 1997 Jul; 115(20-21):24-30. PubMed ID: 9333583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria.
    Tsai MY; Garg U; Key NS; Hanson NQ; Suh A; Schwichtenberg K
    Atherosclerosis; 1996 Apr; 122(1):69-77. PubMed ID: 8724113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency.
    Brattström L; Israelsson B; Lindgärde F; Hultberg B
    Metabolism; 1988 Feb; 37(2):175-8. PubMed ID: 3340005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocystinuria--the effects of betaine in the treatment of patients not responsive to pyridoxine.
    Wilcken DE; Wilcken B; Dudman NP; Tyrrell PA
    N Engl J Med; 1983 Aug; 309(8):448-53. PubMed ID: 6877313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrelations between plasma free and protein-bound homocysteine and cysteine in homocystinuria.
    Wiley VC; Dudman NP; Wilcken DE
    Metabolism; 1988 Feb; 37(2):191-5. PubMed ID: 3340007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine in venous thromboembolism.
    Brattström L; Tengborn L; Lagerstedt C; Israelsson B; Hultberg B
    Haemostasis; 1991; 21(1):51-7. PubMed ID: 1864556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystathionine-beta-synthase deficiency: detection of heterozygotes by the ratios of homocysteine to cysteine and folate.
    Boddie AM; Steen MT; Sullivan KM; Pasquali M; Dembure PP; Coates RJ; Elsas LJ
    Metabolism; 1998 Feb; 47(2):207-11. PubMed ID: 9472972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of coronary artery disease. A possible role for methionine metabolism.
    Wilcken DE; Wilcken B
    J Clin Invest; 1976 Apr; 57(4):1079-82. PubMed ID: 947949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine treatment does not prevent homocystinemia after methionine loading in adult homocystinuria patients.
    Boers GH; Smals AG; Drayer JI; Trijbels FJ; Leermakers AI; Kloppenborg PW
    Metabolism; 1983 Apr; 32(4):390-7. PubMed ID: 6621374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfur amino acids and atherosclerosis: a role for excess dietary methionine.
    Selhub J; Troen AM
    Ann N Y Acad Sci; 2016 Jan; 1363():18-25. PubMed ID: 26647293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.